Journals / Acta Medica / 2019 / Cilt: 50 - Sayı: 4

Infant Acute Lymphoblastic Leukemia with Atypical Presentation

Pages
57–59
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we report a 1-month-old girl presented with high phenylalanine level in national newborn screening program for phenylketonuria; and subsequently diagnosed to have acute lymphoblastic leukemia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Infant leukemia is a very rare disease and consists of 5% of all childhood leukemias.
📊
Key Findings & Data:Infant leukemia usually presents with high leukocyte counts and numerous extra-hematological features including central nervous system and skin involvement.
💡
Conclusion & Impact:Herein, we report a 1-month-old girl presented with high phenylalanine level in national newborn screening program for phenylketonuria; and subsequently diagnosed to have acute lymphoblastic leukemia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Infant leukemia is a very rare disease and consists of 5% of all childhood leukemias. Infant leukemia usually presents with high leukocyte counts and numerous extra-hematological features including central nervous system and skin involvement. Herein, we report a 1-month-old girl presented with high phenylalanine level in national newborn screening program for phenylketonuria; and subsequently diagnosed to have acute lymphoblastic leukemia.

🔖

Cite This Article

BAJİN, İ. Y., YILDIZ, Y., AKIN, Ş., AYTAÇ, S., ÜNAL, Ş., KUŞKONMAZ, B., ÇETİN, M., SİVRİ, S., GÜMRÜK, F. (2019). Infant Acute Lymphoblastic Leukemia with Atypical Presentation. Acta Medica, Cilt: 50 - Sayı: 4, 57–59. https://ajindex.com/articles/143127

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Daisuke Tomizawa. Recent progress in the treatment of acute infant leukemia. Pediatrics International 2015; 57: 811–819
  2. Patrick Brown. Treatment of infant leukemias: challenge and promise. Hematology Am Soc Hematol Educ Program. 2013: 596–600
  3. Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007; 370(9583): 240-250
  4. Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol 2012; 30(14): 1663-1669
  5. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009; 360(26): 2730-2741
  6. Blau N, Curtius AC, Kierat L, Leupold D, Kohne E. Hyperphenylalaninemia caused by dihydropteridine reductase deficiency in children receiving chemotherapy for acute lymphoblastic leukemia. J Pediatr 1989; 115(4):661-3
  7. Turkan Patiroglu, Ekrem Unal, Fatih Kardas et al. Phenylketonuria with Acute Myeloblastic Leukemia in a 9-year-old Boy: Reporting a Rare Case. J Pediatr Hematol Oncol 2011; 33:e256–e257 [8] Cheng Wang, Carol S. Camfield, Conrad V. Fernandez, Terry Hurley, Karen Campbell Clinical Report Successful Neurological Outcome of a Child with Classical Phenylketonuria and Acute Lymphoblastic Leukemia: A 7-Year Follow-Up
  8. Shakespeare L, Downing M, Allen J, Casbolt AM, Ellin S, Maloney M, Race G, Bonham J. Elevated phenylalanine on newborn screening: follow-up testing may reveal undiagnosed galactosaemia. Ann Clin Biochem 2010; 47(Pt 6): 567-9.